Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04532814 · ClinicalTrials.gov registry record · NA
Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity
A NA study of Upper Body Obesity, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT04532814 is a NA study of Upper Body Obesity that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04532814, a NA study of Upper Body Obesity, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to provide the first integrated examination of the interaction between muscle insulin action and exercise-stimulated muscle glucose uptake in obesity from the whole body to the cellular/molecular level.
Conditions Studied
Interventions
- OTHER Exercise
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-11-06 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04532814
The ClinicalTrials.gov registry entry for NCT04532814 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Body Obesity appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT04532814 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04532814 about?
NCT04532814 is a clinical study titled "Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity". The purpose of this study is to provide the first integrated examination of the interaction between muscle insulin action and exercise-stimulated muscle glucose uptake in obesity from the whole body to the cellular/molecular level.
What is the current status of trial NCT04532814?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2020-11-06. Estimated completion is 2026-07-31.
What conditions does trial NCT04532814 study?
This clinical trial studies the following conditions: Upper Body Obesity.
What interventions are being tested in trial NCT04532814?
The interventions under investigation include: Exercise (OTHER).
Who is sponsoring clinical trial NCT04532814?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04532814 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.